| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |